CLINICAL_TRIALS
trial_result
· 2019-06-04
Clinical Trial Update: Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Summary
A Phase 2 dose-ranging study of RPL554 in COPD patients has been completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2019-06-04